trial · primary record
XEN1101
Focal Epilepsy
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 880 |
| Primary completion | 2033-06 |
| Primary endpoint | The adverse events |
| Registry ID | NCT05718817 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:07.359Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05718817
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Xen1101 · compound